TY - JOUR
T1 - Molecular docking and dynamics studies on propolis sulabiroin-A as a potential inhibitor of SARS-CoV-2
AU - Fatriansyah, Jaka Fajar
AU - Rizqillah, Raihan Kenji
AU - Yandi, Muhamad Yusup
AU - Fadilah, Dwitya Nur
AU - Sahlan, Muhamad
N1 - Funding Information:
There are no financial conflicts of interest to disclose. This study was funded by Publikasi Terindeks Internasional (PUTI) Q1 Grant Universitas Indonesia number NKB-1426/UN2.RST/HKP.05.00/2020.
Publisher Copyright:
© 2021 The Author(s)
PY - 2022/1
Y1 - 2022/1
N2 - Molecular docking and dynamics simulations were conducted to investigate the antiviral activity of Propolis Sulabiroin-A to inhibit the SARS-CoV-2 virus with quercetin, hesperidin, and remdesivir as control ligands. The parameters calculated were docking score and binding energy/molecular mechanics-generalized born surface area (MMGBSA), root mean square displacement (RMSD), and root mean square fluctuation (RMSF). Docking and MMGBSA scores showed that all the ligands demonstrate an excellent candidate as an inhibitor, and the order of both scores is hesperidin, remdesivir, quercetin, and sulabiroin-A. The molecular dynamics simulation showed that all the ligands are good candidates as inhibitors. Although the fluctuation of Sulabiroin-A is relatively high, it has less protein–ligand interaction time than other ligands. Overall, there is still a good possibility that sulabiroin-A can be used as an alternative inhibitor if a new structure of receptor SARS-CoV-2 is used.
AB - Molecular docking and dynamics simulations were conducted to investigate the antiviral activity of Propolis Sulabiroin-A to inhibit the SARS-CoV-2 virus with quercetin, hesperidin, and remdesivir as control ligands. The parameters calculated were docking score and binding energy/molecular mechanics-generalized born surface area (MMGBSA), root mean square displacement (RMSD), and root mean square fluctuation (RMSF). Docking and MMGBSA scores showed that all the ligands demonstrate an excellent candidate as an inhibitor, and the order of both scores is hesperidin, remdesivir, quercetin, and sulabiroin-A. The molecular dynamics simulation showed that all the ligands are good candidates as inhibitors. Although the fluctuation of Sulabiroin-A is relatively high, it has less protein–ligand interaction time than other ligands. Overall, there is still a good possibility that sulabiroin-A can be used as an alternative inhibitor if a new structure of receptor SARS-CoV-2 is used.
KW - Drug discovery
KW - Molecular docking
KW - Molecular dynamics
KW - SARS-CoV-2
KW - Sulabiroin-A
UR - http://www.scopus.com/inward/record.url?scp=85119407374&partnerID=8YFLogxK
U2 - 10.1016/j.jksus.2021.101707
DO - 10.1016/j.jksus.2021.101707
M3 - Article
AN - SCOPUS:85119407374
SN - 1018-3647
VL - 34
JO - Journal of King Saud University - Science
JF - Journal of King Saud University - Science
IS - 1
M1 - 101707
ER -